Oncternal Therapeutics, Inc. (ONCT)

Oncternal Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.4	6.7	37.14	90.77	116.74	20.05
Short-Term Investments	20.63	27.56	26.58	0	0	0
Cash & Cash Equivalents	27.03	34.26	63.72	90.77	116.74	20.05
Cash Growth	-50.24%	-46.24%	-29.79%	-22.25%	482.20%	-2.88%
Other Current Assets	1.48	1.8	3.57	2.09	1.27	0.74
Total Current Assets	28.5	36.06	67.29	92.85	118	20.79
Property, Plant & Equipment	0.23	0.26	0.09	0.08	0.04	0.19
Other Long-Term Assets	0.41	0.41	1.27	0.66	0.77	0.77
Total Long-Term Assets	0.64	0.67	1.36	0.73	0.81	0.96
Total Assets	29.14	36.73	68.65	93.59	118.81	21.74
Accounts Payable	1.46	1.15	2.92	1.96	1.14	0.87
Deferred Revenue	0	0	0	0	1.63	3.64
Current Debt	0.18	0.17	0.09	0.08	0.04	0.1
Other Current Liabilities	4.48	3.88	4.68	3.43	3.04	2.73
Total Current Liabilities	6.12	5.2	7.68	5.47	5.86	7.34
Long-Term Debt	0.1	0.15	0	0	0	0.09
Other Long-Term Liabilities	0	1.33	0	0	0	0
Total Long-Term Liabilities	0.1	1.48	0	0	0	0.09
Total Liabilities	6.22	6.68	7.68	5.47	5.86	7.43
Total Debt	0.28	0.32	0.09	0.08	0.04	0.19
Debt Growth	456.00%	265.52%	16.00%	87.50%	-78.95%	-
Retained Earnings	-206.17	-197.78	-158.3	-114.13	-82.8	-65.57
Comprehensive Income	-0.01	0	0.01	0	0	0
Shareholders' Equity	22.93	30.05	60.97	88.12	112.95	14.31
Net Cash / Debt	26.75	33.94	63.64	90.69	116.7	19.86
Net Cash / Debt Growth	-50.71%	-46.67%	-29.83%	-22.29%	487.57%	-3.80%
Net Cash Per Share	9.04	11.54	24.20	36.78	114.94	38.46
Working Capital	22.39	30.86	59.61	87.39	112.15	13.45
Book Value Per Share	7.75	10.22	23.18	35.73	111.25	27.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).